Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Evaluating safety, efficacy, and cost-effectiveness of PICC securement by subcutaneously anchored stabilization device.

Zerla PA, Canelli A, Cerne L, Caravella G, Gilardini A, De Luca G, Aricisteanu AM, Venezia R.

J Vasc Access. 2017 May 15;18(3):238-242. doi: 10.5301/jva.5000655. Epub 2017 Feb 15.

PMID:
28218360
2.

Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy.

Gilardini A, Avila RL, Oggioni N, Rodriguez-Menendez V, Bossi M, Canta A, Cavaletti G, Kirschner DA.

Neurotoxicology. 2012 Jan;33(1):1-7. doi: 10.1016/j.neuro.2011.10.010. Epub 2011 Nov 4.

PMID:
22079976
3.

Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats.

Meregalli C, Canta A, Carozzi VA, Chiorazzi A, Oggioni N, Gilardini A, Ceresa C, Avezza F, Crippa L, Marmiroli P, Cavaletti G.

Eur J Pain. 2010 Apr;14(4):343-50. doi: 10.1016/j.ejpain.2009.07.001. Epub 2009 Aug 19.

PMID:
19695912
4.

Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis.

Cavaletti G, Cassetti A, Canta A, Galbiati S, Gilardini A, Oggioni N, Rodriguez-Menendez V, Fasano A, Liuzzi GM, Fattler U, Ries S, Nieland J, Riccio P, Haas H.

Mol Pharm. 2009 Sep-Oct;6(5):1363-70. doi: 10.1021/mp8001478.

PMID:
19281192
5.

Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity.

Carozzi V, Chiorazzi A, Canta A, Oggioni N, Gilardini A, Rodriguez-Menendez V, Avezza F, Crippa L, Ceresa C, Nicolini G, Bossi M, Cavaletti G.

Eur J Cancer. 2009 Mar;45(4):656-65. doi: 10.1016/j.ejca.2008.10.038. Epub 2008 Dec 16.

PMID:
19091544
6.

Proteasome inhibition: a promising strategy for treating cancer, but what about neurotoxicity?

Gilardini A, Marmiroli P, Cavaletti G.

Curr Med Chem. 2008;15(29):3025-35. Review.

PMID:
19075650
7.

Valproate protective effects on cisplatin-induced peripheral neuropathy: an in vitro and in vivo study.

Rodriguez-Menendez V, Gilardini A, Bossi M, Canta A, Oggioni N, Carozzi V, Tremolizzo L, Cavaletti G.

Anticancer Res. 2008 Jan-Feb;28(1A):335-42.

8.

Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth.

Bianchi R, Gilardini A, Rodriguez-Menendez V, Oggioni N, Canta A, Colombo T, De Michele G, Martone S, Sfacteria A, Piedemonte G, Grasso G, Beccaglia P, Ghezzi P, D'Incalci M, Lauria G, Cavaletti G.

Eur J Cancer. 2007 Mar;43(4):710-7. Epub 2007 Jan 23.

PMID:
17251006
9.

Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.

Cavaletti G, Gilardini A, Canta A, Rigamonti L, Rodriguez-Menendez V, Ceresa C, Marmiroli P, Bossi M, Oggioni N, D'Incalci M, De Coster R.

Exp Neurol. 2007 Mar;204(1):317-25. Epub 2007 Jan 9.

PMID:
17214983
10.

Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.

Bianchi R, Brines M, Lauria G, Savino C, Gilardini A, Nicolini G, Rodriguez-Menendez V, Oggioni N, Canta A, Penza P, Lombardi R, Minoia C, Ronchi A, Cerami A, Ghezzi P, Cavaletti G.

Clin Cancer Res. 2006 Apr 15;12(8):2607-12.

11.

Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats.

Persohn E, Canta A, Schoepfer S, Traebert M, Mueller L, Gilardini A, Galbiati S, Nicolini G, Scuteri A, Lanzani F, Giussani G, Cavaletti G.

Eur J Cancer. 2005 Jul;41(10):1460-6.

PMID:
15913989

Supplemental Content

Loading ...
Support Center